Cabaletta Bio (CABA) Interest Expenses (2024 - 2025)
Cabaletta Bio (CABA) recorded quarterly Interest Expenses of $555000.0 in Q4 2025, down 4.97% quarter-over-quarter from $584000.0 in Q3 2025, and down 25.8% on a YoY basis from $748000.0 in Q4 2024.
Cabaletta Bio (CABA) Interest Expenses (2024 - 2025) Analysis & Trends
Cabaletta Bio's Interest Expenses history runs 2 years deep, the most recent figure standing at $555000.0 for Q4 2025.
- In Q4 2025, Interest Expenses fell 25.8% year-over-year to $555000.0; the TTM figure through Dec 2025 stood at $2.0 million (up 167.91% YoY), while the FY2025 annual figure was $2.0 million, up 167.91% from the prior year.
- Interest Expenses was $555000.0 for Q4 2025 at Cabaletta Bio, down from $584000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $748000.0 in Q4 2024 to a low of $294000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 555,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 555,000.00 |
| Dec 31, 2025 | 555,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 748,000.00 |
| Dec 31, 2024 | 748,000.00 |